| Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani B Purkait, A Kumar, N Nandi, AH Sardar, S Das, S Kumar, K Pandey, ... Antimicrobial agents and chemotherapy 56 (2), 1031-1041, 2012 | 343 | 2012 |
| Asymptomatic infection with visceral leishmaniasis in a disease-endemic area in Bihar, India RK Topno, VNR Das, A Ranjan, K Pandey, D Singh, N Kumar, ... The American journal of tropical medicine and hygiene 83 (3), 502, 2010 | 111 | 2010 |
| Molecular typing of Mycobacterium tuberculosis isolates from different parts of India based on IS6110 element polymorphism using RFLP analysis DS Chauhan, VD Sharma, D Parashar, A Chauhan, D Singh, HB Singh, ... Indian Journal of Medical Research 125 (4), 577-581, 2007 | 106 | 2007 |
| Proteome changes associated with Leishmania donovani promastigote adaptation to oxidative and nitrosative stresses AH Sardar, S Kumar, A Kumar, B Purkait, S Das, A Sen, M Kumar, ... Journal of proteomics 81, 185-199, 2013 | 68 | 2013 |
| Asymptomatic infection of visceral leishmaniasis in hyperendemic areas of Vaishali district, Bihar, India: a challenge to kala-azar elimination programmes VNR Das, NA Siddiqui, RB Verma, RK Topno, D Singh, S Das, A Ranjan, ... Transactions of the Royal Society of Tropical Medicine and Hygiene 105 (11 …, 2011 | 67 | 2011 |
| Development of Post–Kala-Azar Dermal Leishmaniasis (PKDL) in Miltefosine-Treated Visceral Leishmaniasis VNR Das, K Pandey, N Verma, CS Lal, S Bimal, RK Topno, D Singh, ... Am J Trop Med Hyg 80 (3), 336-338, 2009 | 53 | 2009 |
| Validation of SYBR green I based closed tube loop mediated isothermal amplification (LAMP) assay and simplified direct-blood-lysis (DBL)-LAMP assay for diagnosis of visceral … KK Dixit, S Verma, OP Singh, D Singh, AP Singh, R Gupta, NS Negi, ... PLoS neglected tropical diseases 12 (11), e0006922, 2018 | 51 | 2018 |
| Screening sandflies for natural infection with Leishmania donovani, using a non-radioactive probe based on the total DNA of the parasite DS Dinesh, SK Kar, K Kishore, A Palit, N Verma, AK Gupta, DS Chauhan, ... Annals of Tropical Medicine & Parasitology 94 (5), 447-451, 2000 | 43 | 2000 |
| Clinical epidemiologic profile of a cohort of post–kala-azar dermal leishmaniasis patients in Bihar, India VNR Das, A Ranjan, K Pandey, D Singh, N Verma, S Das, CS Lal, ... The American journal of tropical medicine and hygiene 86 (6), 959, 2012 | 42 | 2012 |
| TGF‐β1 re‐programs TLR4 signaling in L. donovani infection: enhancement of SHP‐1 and ubiquitin‐editing enzyme A20 S Das, K Pandey, A Kumar, AH Sardar, B Purkait, M Kumar, S Kumar, ... Immunology and cell biology 90 (6), 640-654, 2012 | 41 | 2012 |
| Comparative analysis of serum zinc, copper, magnesium, calcium and iron level in acute and chronic patients of visceral leishmaniasis CS Lal, S Kumar, A Ranjan, VN Rabidas, N Verma, K Pandey, RB Verma, ... Journal of Trace Elements in Medicine and Biology 27 (2), 98-102, 2013 | 39 | 2013 |
| Typing of drug resistant isolates of Mycobacterium tuberculosis from India using the IS6110 element reveals substantive polymorphism N Siddiqi, M Shamim, A Amin, DS Chauhan, R Das, K Srivastava, D Singh, ... Infection, Genetics and Evolution 1 (2), 109-116, 2001 | 39 | 2001 |
| Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India K Pandey, VNR Das, D Singh, S Das, CS Lal, N Verma, S Bimal, ... Journal of clinical microbiology 50 (4), 1478-1479, 2012 | 38 | 2012 |
| Diagnosis of visceral leishmaniasis in Bihar India: comparison of the rK39 rapid diagnostic test on whole blood versus serum G Matlashewski, VNR Das, K Pandey, D Singh, S Das, AK Ghosh, ... PLoS Neglected Tropical Diseases 7 (5), e2233, 2013 | 37 | 2013 |
| Up-regulation of silent information regulator 2 (Sir2) is associated with amphotericin B resistance in clinical isolates of Leishmania donovani B Purkait, R Singh, K Wasnik, S Das, A Kumar, M Paine, M Dikhit, D Singh, ... Journal of Antimicrobial Chemotherapy 70 (5), 1343-1356, 2015 | 34 | 2015 |
| Drug susceptibility profiles of Mycobacterium tuberculosis isolates at Jaipur. B Malhotra, S Pathak, L Vyas, VM Katoch, K Srivastava, DS Chauhan, ... Indian Journal of Medical Microbiology 20 (2), 76-78, 2002 | 33 | 2002 |
| Evaluation of rK-39 strip test using urine for diagnosis of visceral leishmaniasis in an endemic region of India D Singh, K Pandey, VNR Das, S Das, N Verma, A Ranjan, SC Lal, ... The American journal of tropical medicine and hygiene 88 (2), 222, 2013 | 32 | 2013 |
| A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive … VNR Das, NA Siddiqui, K Pandey, VP Singh, RK Topno, D Singh, ... Therapeutics and Clinical Risk Management, 117-124, 2009 | 31 | 2009 |
| Drug targets in dormant Mycobacterium tuberculosis: can the conquest against tuberculosis become a reality? VK Gupta, MM Kumar, D Singh, D Bisht, S Sharma Infectious Diseases 50 (2), 81-94, 2018 | 29 | 2018 |
| Combination of paromomycin and miltefosine promotes TLR4-dependent induction of antileishmanial immune response in vitro S Das, M Rani, K Pandey, GC Sahoo, VN Rabidas, D Singh, P Das Journal of antimicrobial chemotherapy 67 (10), 2373-2378, 2012 | 28 | 2012 |
Dr Krishna PandeyDirector & Scientist-G, ICMR-RMRIMS, Patna在 icmr.gov.in 的电子邮件经过验证
